Request Demo
Last update 20 Dec 2025
CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)
Last update 20 Dec 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)ChiCTR2400092462
An open-label clinical study to evaluate the safety and pharmacodynamics of QH103 cell injection (CD19 CAR-γδT cells) in the treatment of relapsed/refractory autoimmune diseases
NCT02546739
Phase I Study of T Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults With B Cell Malignancies
NCT02656147
Phase I Study of γδT Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults With B Cell Malignancies
100 Clinical Results associated with CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)
Login to view more data
100 Translational Medicine associated with CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)
Login to view more data
100 Patents (Medical) associated with CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)
Login to view more data
100 Deals associated with CD19 CAR-γδT (Beijing DOING Biomedical technology Co.,ltd)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | China | 01 Oct 2017 | |
| CD19 Expressing Malignancies | Phase 1 | China | 01 Oct 2017 | |
| Chronic Lymphocytic Leukemia | Phase 1 | China | 01 Oct 2017 | |
| Recurrent B Acute Lymphoblastic Leukemia | Phase 1 | China | 01 Oct 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free